Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

86%

6 of 7 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

N/A

9(90.0%)

Phase 4

1(10.0%)

10Total

N/A(9)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05784558Withdrawn

RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up

Role: lead

NCT05148156Not ApplicableSuspended

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Role: collaborator

NCT05311527Not ApplicableCompleted

UroLift System With SAbR for Prostate Cancer and BPH

Role: collaborator

NCT04338776Not ApplicableActive Not Recruiting

Comparing UroLift Experience Against Rezūm

Role: lead

NCT04987892Phase 4Unknown

Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH

Role: lead

NCT03194737Not ApplicableCompleted

Prostatic Urethral Lift in Subject With Acute Urinary Retention

Role: lead

NCT04271020Not ApplicableCompleted

Urodynamic Feasibility Study Utilizing the UroLift® System

Role: lead

NCT01876706Not ApplicableCompleted

UroLift System TOlerability and ReCovery When Administering Local Anesthesia

Role: lead

NCT02625545Not ApplicableCompleted

Study of Median Lobe Prostatic UroLift Procedure

Role: lead

NCT01294150Not ApplicableCompleted

The Safety and Effectiveness of UroLift: LIFT Pivotal Study

Role: lead

NCT01533038Not ApplicableCompleted

BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia

Role: lead

All 11 trials loaded